Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
SCTV04C
- Development stage
- Phase 2
- Lead developer
- Sinocelltech
- Modality
- Recombinant Proteins and Enzymes, Recombinant Protein Vaccines → Recombinant Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics
- Administration
- Intramuscular
01
Overview
SCTV04C is a recombinant protein-based herpes zoster (shingles) vaccine developed for the prevention of shingles caused by the varicella zoster virus. It is designed as a prophylactic genetically engineered subunit vaccine, aiming to induce an immune response against the varicella zoster virus in adults. The drug is currently being evaluated in clinical trials for its safety, tolerability, and immunogenicity at different dose levels in healthy subjects aged 40 years and older[1][2][3][9]. The developer behind this candidate is Sinocelltech (also referred to as Shenzhou Cell Engineering).
- Brand names
- SCTV04CSCTV-04CSCTV 04C
- Other names
- recombinant herpes zoster vaccine SCTV04Crecombinant herpes zoster vaccine (Sinocelltech)recombinant herpes zoster vaccine (Shenzhou Cell Engineering)
02
Targets
gE (VZV glycoprotein E)
Beyond the preview
Go deeper on SCTV04C.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on SCTV04C.